Ortacta (Rivaroxaban) is a highly effective anticoagulant medication prescribed to prevent blood clots and reduce the risk of stroke in patients with atrial fibrillation. This 10mg tablet is part of the novel oral anticoagulants (NOACs) class, offering a convenient once-daily dosing regimen. Rivaroxaban works by selectively inhibiting Factor Xa, a key enzyme in the blood clotting process, thereby preventing the formation of harmful clots without the need for routine blood monitoring. It is widely recommended for patients with non-valvular atrial fibrillation and those undergoing knee or hip replacement surgery to minimize clot-related complications.